GE Healthcare Expands High-Content Screening Offerings with Two Pacts | GenomeWeb
NEW YORK (GenomeWeb News) – GE Healthcare has signed agreements with two separate firms intended to expand its offerings in the high-content cell screening field, the firm announced today.
 
The first pact is with Process Analysis and Automation, under which PAA will provide automated hardware and software for GE Healthcare’s IN Cell Analyzer and LEADseeker platforms.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.